Krystyna Skupinska

Krystyna Skupinska is a notable inventor based in New Westminster, Canada. She has made significant contributions to the field of chemistry, particularly in the development of compounds that interact with chemokine receptors. With a total of 3 patents to her name, her work has implications for treating various medical conditions.

Latest Patents

One of her latest patents is focused on CXCR4 chemokine receptor binding compounds. This invention relates to compounds that bind to chemokine receptors and includes methods for treating HIV infection and inflammatory conditions such as rheumatoid arthritis. Additionally, it outlines methods to elevate progenitor and stem cell counts, as well as white blood cell counts using these compounds. Another significant patent involves chemokine receptor binding heterocyclic compounds with enhanced efficacy. These compounds are designed to interact with the CXCR4 receptor and are useful in treating HIV infection, inflammatory conditions, asthma, and cancer.

Career Highlights

Krystyna Skupinska is currently associated with Genzyme Corporation, where she continues to innovate and contribute to the field of biochemistry. Her work has been instrumental in advancing therapeutic options for various diseases.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as Gary James Bridger and Ernest John McEachern. These collaborations have further enriched her research and development efforts.

Conclusion

Krystyna Skupinska's innovative work in the field of chemokine receptor binding compounds showcases her dedication to advancing medical science. Her contributions are paving the way for new treatments and improving patient outcomes.

Profile summary based on public USPTO records.